Mitochondria-targeted peptide SS31 improves mitochondrial structural damage and alleviates renal injury in DKD via increasing the expression of Mfn1 and inhibiting the expression of Drp1 [204]. The gene discussed is DNM1L; the disease is diabetic kidney disease.